17β-Estradiol Induces Apoptosis in the Preosteoclastic FLG 29.1 Cell Line
- 24 February 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 255 (3) , 680-685
- https://doi.org/10.1006/bbrc.1999.0215
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Estrogen Deficiency Increases the Ability of Stromal Cells to Support Murine Osteoclastogenesis via an Interleukin-1and Tumor Necrosis Factor-mediated Stimulation of Macrophage Colony-stimulating Factor ProductionJournal of Biological Chemistry, 1996
- Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosisJournal of Bone and Mineral Research, 1996
- The Effect of Postmenopausal Estrogen Therapy on Bone Density in Elderly WomenNew England Journal of Medicine, 1993
- Cytokines and Estrogen in Bone: Anti-Osteoporotic EffectsScience, 1993
- Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal WomenAnnals of Internal Medicine, 1992
- 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens.Journal of Clinical Investigation, 1992
- Bone‐cell changes in estrogen‐induced bone‐mass increase in mice: Dissociation of osteoclasts from bone surfacesThe Anatomical Record, 1991
- A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosisBone, 1989
- Evidence of Estrogen Receptors in Normal Human Osteoblast-Like CellsScience, 1988
- Histologic evidence for osteopenia and increased bone turnover in ovariectomized ratsBone, 1986